pyrazolanthrone has been researched along with calcitriol in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Adachi, T; Hara, H; Iwamura, T; Kataoka, T; Yasunami, Y | 1 |
Fukumori, S; Hashimoto, Y; Murata, T; Taguchi, M | 1 |
Hagberg, M; Johansson, V; Kjellberg, C; Larsson, D; Malek, N; Senneberg, E; Tahmasebifar, N | 1 |
Reddy, SV; Sambandam, Y; Sundaram, K; Tsuruga, E; Wagner, CL | 1 |
Chao, CY; Cheng, YH; Chiang, EI; Lin, CC; Lin, HY; Syu, JN; Tang, FY; Tsai, SY; Yang, MD | 1 |
6 other study(ies) available for pyrazolanthrone and calcitriol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
C-jun N-terminal kinase modulates 1,25-dihydroxyvitamin D3-induced cytochrome P450 3A4 gene expression.
Topics: Anthracenes; Caco-2 Cells; Calcitriol; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Humans; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Receptors, Calcitriol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic | 2004 |
Rapid and drastic induction of CYP3A4 mRNA expression via vitamin D receptor in human intestinal LS180 cells.
Topics: Anthracenes; Calcitriol; Cell Line; Curcumin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Enzyme Induction; Humans; Hydroxylation; Intestinal Mucosa; JNK Mitogen-Activated Protein Kinases; Lithocholic Acid; Molecular Structure; Protein Kinase Inhibitors; Receptors, Calcitriol; RNA, Messenger; Staurosporine; Time Factors; Vitamin D | 2007 |
Membrane initiated signaling by 1,25alpha-dihydroxyvitamin D3 in LNCaP prostate cancer cells.
Topics: Anthracenes; Cell Proliferation; Drug Therapy, Combination; Humans; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Signal Transduction; Tumor Cells, Cultured; Vitamin D | 2008 |
1α,25-dihydroxyvitamin D3 modulates CYP2R1 gene expression in human oral squamous cell carcinoma tumor cells.
Topics: Anthracenes; Blotting, Western; Calcitriol; Carcinoma, Squamous Cell; Cell Line, Tumor; Cholestanetriol 26-Monooxygenase; Cytochrome P450 Family 2; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; Mouth Neoplasms; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Receptors, Calcitriol; Reverse Transcriptase Polymerase Chain Reaction; Tissue Array Analysis; Vitamins | 2014 |
Treatment of 13-cis retinoic acid and 1,25-dihydroxyvitamin D3 inhibits TNF-alpha-mediated expression of MMP-9 protein and cell invasion through the suppression of JNK pathway and microRNA 221 in human pancreatic adenocarcinoma cancer cells.
Topics: Adenocarcinoma; Anthracenes; Calcitriol; Cell Line, Tumor; Cell Movement; Cell Survival; Humans; Isotretinoin; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Matrix Metalloproteinase 9; MicroRNAs; Neoplasm Invasiveness; NF-kappa B; Pancreatic Neoplasms; Phosphorylation; Tissue Inhibitor of Metalloproteinase-3; Transfection; Tumor Necrosis Factor-alpha; Up-Regulation | 2021 |